• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种模拟雄激素反应元件的合成适配体对LNCaP细胞系的抗增殖作用。

Antiproliferative effect of a synthetic aptamer mimicking androgen response elements in the LNCaP cell line.

作者信息

Kouhpayeh S, Einizadeh A R, Hejazi Z, Boshtam M, Shariati L, Mirian M, Darzi L, Sojoudi M, Khanahmad H, Rezaei A

机构信息

Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Department of Biology, International Pardis, University of Guilan, Rasht, Iran.

出版信息

Cancer Gene Ther. 2016 Aug;23(8):254-7. doi: 10.1038/cgt.2016.26. Epub 2016 Jul 1.

DOI:10.1038/cgt.2016.26
PMID:27364573
Abstract

Prostate cancer usually develops to a hormone-refractory state that is irresponsive to conventional therapeutic approaches. Therefore, new methods for treating aggressive prostate cancer are under development. Because of the importance of androgen receptors (ARs) in the development of the hormone-refractory state and AR mechanism of action, this study was designed. A single-stranded DNA as an aptamer was designed that could mimic the hormone response element (HRE). The LNCaP cells as an AR-rich model were divided into three sets of triplicate groups: the test group was transfected with Aptamer Mimicking HRE (AMH), Mock received only transfection reagents (mock) and a negative control. All three sets received 0, 10 and 100 nM of dehydroepiandrosterone (DHEA) separately. Data analysis showed hormone dependency of LNCaP cells in the negative control group upon treatment with 10 and 100 nM DHEA (compared with cells left untreated (P=0.001)). Transfection of AMH resulted in significant reduction of proliferation in the test group when compared with the negative control group with 10 (P=0.001) or 100 nM DHEA (P=0.02). AMH can form a hairpin structure at 37 °C and mimic the genomic HRE. Hence, it is capable of effectively competing with genomic HRE and interrupting the androgen signaling pathway in a prostate cancer cell line (LNCaP).

摘要

前列腺癌通常会发展到对传统治疗方法无反应的激素难治性状态。因此,正在研发治疗侵袭性前列腺癌的新方法。鉴于雄激素受体(ARs)在激素难治性状态发展及AR作用机制中的重要性,开展了本研究。设计了一种可模拟激素反应元件(HRE)的单链DNA适配体。将富含AR的LNCaP细胞分为三组,每组三个重复:试验组用模拟HRE的适配体(AMH)转染,对照组仅接受转染试剂(mock)作为阴性对照。所有三组分别接受0、10和100 nM的脱氢表雄酮(DHEA)。数据分析显示,阴性对照组的LNCaP细胞在用10和100 nM DHEA处理后具有激素依赖性(与未处理的细胞相比,P=0.001)。与用10 nM(P=0.001)或100 nM DHEA处理的阴性对照组相比,AMH转染导致试验组细胞增殖显著减少(P=0.02)。AMH在37°C时可形成发夹结构并模拟基因组HRE。因此,它能够有效竞争基因组HRE并中断前列腺癌细胞系(LNCaP)中的雄激素信号通路。

相似文献

1
Antiproliferative effect of a synthetic aptamer mimicking androgen response elements in the LNCaP cell line.一种模拟雄激素反应元件的合成适配体对LNCaP细胞系的抗增殖作用。
Cancer Gene Ther. 2016 Aug;23(8):254-7. doi: 10.1038/cgt.2016.26. Epub 2016 Jul 1.
2
Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.雄激素受体编码区域中的两个雄激素反应元件是受体信使核糖核酸细胞特异性上调所必需的。
Mol Endocrinol. 1996 Dec;10(12):1582-94. doi: 10.1210/mend.10.12.8961268.
3
MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.微小RNA-185下调LNCaP前列腺癌细胞系中的雄激素受体表达。
Mol Med Rep. 2015 Jun;11(6):4625-32. doi: 10.3892/mmr.2015.3332. Epub 2015 Feb 11.
4
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.雄激素受体表达增加使前列腺癌细胞对低水平雄激素敏感。
Cancer Res. 2009 Oct 15;69(20):8141-9. doi: 10.1158/0008-5472.CAN-09-0919. Epub 2009 Oct 6.
5
Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.前列腺癌基质细胞和 LNCaP 细胞通过从脱氢表雄酮合成睾酮和二氢睾酮来共同激活雄激素受体。
Endocr Relat Cancer. 2009 Dec;16(4):1139-55. doi: 10.1677/ERC-09-0070. Epub 2009 Jul 16.
6
Androgen-dependent regulation of Her-2/neu in prostate cancer cells.雄激素对前列腺癌细胞中Her-2/neu的依赖性调控。
Cancer Res. 2006 Jun 1;66(11):5723-8. doi: 10.1158/0008-5472.CAN-05-3928.
7
Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.抑制SULT2B1b表达会改变3β-羟基类固醇对人LNCaP前列腺癌细胞增殖和类固醇激素受体表达的影响。
Prostate. 2007 Sep 1;67(12):1318-29. doi: 10.1002/pros.20615.
8
Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.威尔姆斯肿瘤抑制基因WT1对雄激素信号通路的转录调控。
Anticancer Res. 2001 Jan-Feb;21(1A):1-10.
9
c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.c-Jun增强雄激素受体反式激活与前列腺癌细胞增殖相关。
Oncogene. 2006 Nov 16;25(54):7212-23. doi: 10.1038/sj.onc.1209705. Epub 2006 May 29.
10
Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.雄激素去除引发前列腺癌中AR稳定和反式激活对PP1的依赖性。
Prostate. 2016 May;76(7):649-61. doi: 10.1002/pros.23157. Epub 2016 Feb 5.

引用本文的文献

1
Generation of HBsAg DNA aptamer using modified cell-based SELEX strategy.采用改良的基于细胞的 SELEX 策略生成 HBsAg DNA 适体。
Mol Biol Rep. 2021 Jan;48(1):139-146. doi: 10.1007/s11033-020-05995-2. Epub 2021 Jan 5.
2
Oligonucleotide aptamers: potential novel molecules against viral hepatitis.寡核苷酸适配体:对抗病毒性肝炎的潜在新型分子。
Res Pharm Sci. 2017 Apr;12(2):88-98. doi: 10.4103/1735-5362.202447.

本文引用的文献

1
Generation of Aptamers with an Expanded Chemical Repertoire.具有扩展化学文库的适体的生成。
Molecules. 2015 Sep 14;20(9):16643-71. doi: 10.3390/molecules200916643.
2
Using a sequence of estrogen response elements as a DNA aptamer for estrogen receptors in vitro.体外使用一系列雌激素反应元件作为雌激素受体的DNA适配体。
Nucleic Acid Ther. 2015 Jun;25(3):152-61. doi: 10.1089/nat.2014.0521. Epub 2015 Mar 3.
3
Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy.西妥昔单抗治疗前列腺癌:基于证据对其在治疗中的地位的综述
Core Evid. 2014 Dec 18;10:1-10. doi: 10.2147/CE.S54712. eCollection 2015.
4
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
5
DNA aptamer evolved by cell-SELEX for recognition of prostate cancer.通过细胞指数富集的配体系统进化技术筛选出的用于识别前列腺癌的DNA适配体。
PLoS One. 2014 Jun 23;9(6):e100243. doi: 10.1371/journal.pone.0100243. eCollection 2014.
6
High-risk prostate cancer-classification and therapy.高危前列腺癌——分类与治疗
Nat Rev Clin Oncol. 2014 Jun;11(6):308-23. doi: 10.1038/nrclinonc.2014.68. Epub 2014 May 20.
7
Novel agents in the management of castration resistant prostate cancer.去势抵抗性前列腺癌治疗中的新型药物
J Carcinog. 2014 Mar 5;13:5. doi: 10.4103/1477-3163.128185. eCollection 2014.
8
Current approaches, challenges and future directions for monitoring treatment response in prostate cancer.前列腺癌治疗反应监测的当前方法、挑战及未来方向
J Cancer. 2014 Jan 1;5(1):3-24. doi: 10.7150/jca.7709.
9
Advances in aptamer screening and small molecule aptasensors.适体筛选与小分子适体传感器的研究进展。
Adv Biochem Eng Biotechnol. 2014;140:29-67. doi: 10.1007/10_2013_225.
10
Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines.长链非编码RNA GAS5调节前列腺癌细胞系中的细胞凋亡。
Biochim Biophys Acta. 2013 Oct;1832(10):1613-23. doi: 10.1016/j.bbadis.2013.05.005. Epub 2013 May 12.